Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng et al
=========================================================================================================================================================================================

* Vidya Sankar Viswanathan
* Mohammadhadi Khorrami
* Khalid Jazieh
* Pingfu Fu
* Nathan Pennell
* Anant Madabhushi